N-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide

C70H76F6N10O8S2Si2 — CID 158180178

IUPACN-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide
SMILESCc1ccc(S(=O)(=O)n2ccc3c(C(c4nc5cc(C#N)ccc5n4COCC[Si](C)(C)C)N(C)C(=O)C(F)(F)F)c(C)cc(C)c32)cc1.Cc1ccc(S(=O)(=O)n2ccc3c(C(c4nc5ccc(C#N)cc5n4COCC[Si](C)(C)C)N(C)C(=O)C(F)(F)F)c(C)cc(C)c32)cc1
InChIInChI=1S/2C35H38F3N5O4SSi/c1-22-8-11-26(12-9-22)48(45,46)43-15-14-27-30(23(2)18-24(3)31(27)43)32(41(4)34(44)35(36,37)38)33-40-28-19-25(20-39)10-13-29(28)42(33)21-47-16-17-49(5,6)7;1-22-8-11-26(12-9-22)48(45,46)43-15-14-27-30(23(2)18-24(3)31(27)43)32(41(4)34(44)35(36,37)38)33-40-28-13-10-25(20-39)19-29(28)42(33)21-47-16-17-49(5,6)7/h2*8-15,18-19,32H,16-17,21H2,1-7H3
InChIKeyFYMJLJHHLDQKNL-UHFFFAOYSA-N
MW1419.73 g/mol
LogP14.89
Rot. Bonds20

About N-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide

N-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide (PubChem CID 158180178) has the molecular formula C70H76F6N10O8S2Si2 and a molecular weight of 1419.73 g/mol. Its IUPAC name is N-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide.

Molecular Properties

Compound NameN-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide
PubChem CID158180178
Molecular FormulaC70H76F6N10O8S2Si2
Molecular Weight1419.73 g/mol
Exact Mass1418.47
IUPAC NameN-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide
SMILESCc1ccc(S(=O)(=O)n2ccc3c(C(c4nc5cc(C#N)ccc5n4COCC[Si](C)(C)C)N(C)C(=O)C(F)(F)F)c(C)cc(C)c32)cc1.Cc1ccc(S(=O)(=O)n2ccc3c(C(c4nc5ccc(C#N)cc5n4COCC[Si](C)(C)C)N(C)C(=O)C(F)(F)F)c(C)cc(C)c32)cc1
InChIInChI=1S/2C35H38F3N5O4SSi/c1-22-8-11-26(12-9-22)48(45,46)43-15-14-27-30(23(2)18-24(3)31(27)43)32(41(4)34(44)35(36,37)38)33-40-28-19-25(20-39)10-13-29(28)42(33)21-47-16-17-49(5,6)7;1-22-8-11-26(12-9-22)48(45,46)43-15-14-27-30(23(2)18-24(3)31(27)43)32(41(4)34(44)35(36,37)38)33-40-28-13-10-25(20-39)19-29(28)42(33)21-47-16-17-49(5,6)7/h2*8-15,18-19,32H,16-17,21H2,1-7H3
InChIKeyFYMJLJHHLDQKNL-UHFFFAOYSA-N
XLogP14.89
TPSA220.44 Ų
H-Bond Donors
H-Bond Acceptors16
Rotatable Bonds20
Heavy Atoms98
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001419.73
LogP ≤ 514.89
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze N-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide?
The IUPAC name of N-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide (CID 158180178) is N-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide.
What is the SMILES notation for N-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide?
The canonical SMILES for N-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide is Cc1ccc(S(=O)(=O)n2ccc3c(C(c4nc5cc(C#N)ccc5n4COCC[Si](C)(C)C)N(C)C(=O)C(F)(F)F)c(C)cc(C)c32)cc1.Cc1ccc(S(=O)(=O)n2ccc3c(C(c4nc5ccc(C#N)cc5n4COCC[Si](C)(C)C)N(C)C(=O)C(F)(F)F)c(C)cc(C)c32)cc1.
What is the InChIKey of N-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide?
The InChIKey is FYMJLJHHLDQKNL-UHFFFAOYSA-N. The full InChI is InChI=1S/2C35H38F3N5O4SSi/c1-22-8-11-26(12-9-22)48(45,46)43-15-14-27-30(23(2)18-24(3)31(27)43)32(41(4)34(44)35(36,37)38)33-40-28-19-25(20-39)10-13-29(28)42(33)21-47-16-17-49(5,6)7;1-22-8-11-26(12-9-22)48(45,46)43-15-14-27-30(23(2)18-24(3)31(27)43)32(41(4)34(44)35(36,37)38)33-40-28-13-10-25(20-39)19-29(28)42(33)21-47-16-17-49(5,6)7/h2*8-15,18-19,32H,16-17,21H2,1-7H3.
What are the key properties of N-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide?
N-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide has a molecular weight of 1419.73 g/mol, XLogP of 14.89, 20 rotatable bonds, 0 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[5-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide;N-[[6-cyano-1-(2-trimethylsilylethoxymethyl)benzimidazol-2-yl]-[5,7-dimethyl-1-(4-methylphenyl)sulfonylindol-4-yl]methyl]-2,2,2-trifluoro-N-methylacetamide is sourced from PubChem (CID 158180178), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).